Kevin Roehle

1PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Kevin Roehle, Li Qiang, Katherine S Ventre

Pageof 1

Frequent Collaborators

1 joint publications

Li Qiang

1 joint publications

Katherine S Ventre

1 joint publications

Daniel Heid

1 joint publications

Lestat R Ali